This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $224,952
Targeted delivery of antisense-mediated exon skipping therapy in transgenic pig model of DMD
CIHR · 2013 · Principal investigator
Targeted delivery of antisense-mediated exon skipping therapy in transgenic pig model of DMD
Principal investigators: Yokota, Toshifumi; Yin, haifang
Keywords: Muscular Dystrophy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.